Sign Up to like & get
recommendations!
0
Published in 2021 at "Bone Reports"
DOI: 10.1016/j.bonr.2021.101090
Abstract: Purpose Denosumab reduces bone resorption and improves bone mineral density (BMD). Studies have analyzed subsequent treatment transitioning from bisphosphonates to denosumab based on dual-energy X-ray absorptiometry scanning (DXA). Quantitative computed tomography (QCT) can help assess…
read more here.
Keywords:
subsequent treatment;
treatment;
prior bisphosphonate;
group ... See more keywords